Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

J S Wefel; A E Kayl; C A Meyers

doi:10.1038/sj.bjc.6601772

Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

Br J Cancer. 2004 May 4;90(9):1691-6. doi: 10.1038/sj.bjc.6601772.

Authors

J S Wefel¹, A E Kayl, C A Meyers

Affiliation

¹ Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston, TX 77030-4009, USA.

Abstract

Neuropsychological dysfunction associated with cancer and cancer treatment is a growing concern. Methodological limitations permeate the corpus of research in this area and have limited our understanding of the multifactorial nature of this process. The following review provides a summary of the current state of knowledge and highlights future directions.

Publication types

Review

MeSH terms

Animals
Antineoplastic Agents / adverse effects*
Central Nervous System Neoplasms / therapy*
Cognition / drug effects*
Hormones / adverse effects
Hormones / therapeutic use
Humans
Immunotherapy / adverse effects
Mental Disorders / chemically induced*
Neuropsychological Tests
Radiotherapy / adverse effects*

Substances

Antineoplastic Agents
Hormones